Tailored Treatment To Mrd Response: A Phase I/Ii Study For Newly Diagnosed Multiple Myeloma Patients Using High Dose Twice-Weekly Carfilzomib (45 And 56 Mg/M(2)) In Combination With Lenalidomide And DexamethasoneNeha Korde,Donna Mastey,Elizabet Tavitian,Sham Mailankody,Alexander Lesokhin,Hani Hassoun,Eric L Smith,Nikoletta Lendvai,Malin Hultcrantz,Urvi Shah,Carlyn Tan,Sydney Lu,Benjamin Diamond,Meghan Salcedo,Kelly Werner,David J Chung,Michael Scordo,Gunjan L Shah,Oscar Lahoud,Heather Landau,Maria Arcila,Caleb Ho,Mikhail Roshal,Ahmet Dogan,Andriy Derkach,Sean M Devlin,Sergio A Giralt,Ola LandgrenAMERICAN JOURNAL OF HEMATOLOGY（2021）引用 10|浏览16暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
